title: Point and counterpoint. Radical cystectomy or multimodality therapy for TCC of the bladder?
authors.affiliation: Genito-Urinary Oncology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
authors.forename: A L
authors.initials: AL
authors.lastname: Zietman
authors.forename: W U
authors.initials: WU
authors.lastname: Shipley
authors.forename: D S
authors.initials: DS
authors.lastname: Kaufman
authors.forename: D
authors.initials: D
authors.lastname: Esrig
authors.forename: B
authors.initials: B
authors.lastname: Lytton
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000401:mortality / Q000601:surgery* / Q000628:therapy*; D003131:Combined Modality Therapy; D015653:Cystectomy; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008297:Male; D018714:Radiotherapy, Adjuvant; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000401:mortality / Q000601:surgery* / Q000628:therapy*